Michael Mollerus

Davis Polk is advising Roche on its $1.9 billion acquisition of Flatiron Health, Inc. The transaction, which is expected to close in the first half of 2018, is subject to customary closing…

Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $800 million acquisition of MPI Research Inc. The transaction, which is expected to close early in…

Davis Polk advised the underwriters in connection with a public offering by IBM Credit LLC of $450 million principal amount of its floating-rate notes due 2021, $800 million principal…

Davis Polk advised Dufry AG (Dufry) and its subsidiary, Hudson Ltd., in connection with the $748.9 million initial public offering of 39,417,765 Class A common shares of Hudson Ltd. The…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 8,152,986 shares of common stock of…

Davis Polk is advising SS&C Technologies Holdings, Inc. on its approximately $5.4 billion acquisition of DST Systems, Inc. The transaction, which is expected to close by the third…

Davis Polk advised BR Distribuidora S.A. in connection with the initial public offering by Petróleo Brasileiro S.A. — Petrobras, the controlling shareholder of BR, of 334,937,500 common…

Davis Polk advised the underwriter in connection with the SEC-registered offering of 7,500,000 shares of common stock of OneMain Holdings, Inc. sold by Springleaf Financial Holdings,…

Davis Polk advised the sole book-running manager in connection with an SEC-registered common stock offering of 10,000,000 shares of common stock of Tellurian Inc. The net proceeds from…

Davis Polk advised the underwriter in connection with the $45.2 million SEC-registered secondary offering of 5,579,978 shares of common stock of Ardmore Shipping Corporation. The…